Elanco New Zealand competitive analysis

Loading summary...

Explore Elanco New Zealand's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 16, 2024Controlled Release Compositions And Their Methods Of Use1
Oct 2, 2019Injectable Antibiotic Formulations And Their Methods Of Use2

Latest publications and patents of Elanco New Zealand New

Explore the latest publications and patents granted to Elanco New Zealand, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Elanco New Zealand

Oct 16, 2024Controlled Release Compositions And Their Methods Of UsePatent Maintained As Amended
Oct 2, 2019Injectable Antibiotic Formulations And Their Methods Of UseOpposition Rejected

Latest PTAB cases involving Elanco New Zealand

Discover the latest PTAB cases involving Elanco New Zealand, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elanco New Zealand with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELANCO NEW ZEALAND - 3 - -
BOEHRINGER INGELHEIM ANIMAL HEALTH USA16302 -
EUROVET ANIMAL HEALTH1 - - -
OMNIPHARM DEVELOPMENTS1 - - -